<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04000178</url>
  </required_header>
  <id_info>
    <org_study_id>217</org_study_id>
    <nct_id>NCT04000178</nct_id>
  </id_info>
  <brief_title>SILICONE VERSUS POLYURETHANE URETERAL STENTS DURING ACUTE RENAL COLIC</brief_title>
  <official_title>COMPARISON OF SILICONE VERSUS POLYURETHANE URETERAL STENTS: A PROSPECTIVE CONTROLLED STUDY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Petersburg State Pavlov Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Petersburg State Pavlov Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      From June 2018 to October 2018, patients from two distinct clinical centers were
      prospectively enrolled in the study and stratified (non-randomly) into either control group
      A, patients who received polyurethane stents (RÃ¼sch, Teleflex), or experimental group B,
      patients who received silicone stents (Cook Medical). Each participant completed a survey one
      hour after stent insertion, in the middle of the stent dwelling period, and before stent
      removal or ureteroscopy noting body pain and overactive bladder via the visual analog scale
      pain (VASP) and overactive bladder (OAB) awareness tool, respectively. Additionally, the
      successfulness of stent placement, hematuria, number of unplanned visits, and stent
      encrustation rates were assessed within each group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">October 10, 2018</completion_date>
  <primary_completion_date type="Actual">October 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body pain</measure>
    <time_frame>4 weeks</time_frame>
    <description>At each follow-up appointment, patients completed a survey in which the visual analog scale pain (VASP) was filled</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bladder overactivity</measure>
    <time_frame>4 weeks</time_frame>
    <description>At each follow-up appointment, patients completed a survey in which the &quot;bladder awareness tool&quot; (VASP) was filled</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Ureteral Stent Occlusion</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients who received polyurethane stents</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients who received silicone stents</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>polyurethane stent</intervention_name>
    <description>patients were prospectively enrolled in the study and stratified (non-randomly) into either group A - polyurethane - control group or group B - silicone - experimental group</description>
    <arm_group_label>group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>silicone stent</intervention_name>
    <description>silicone stent</description>
    <arm_group_label>group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion criteria included age (18 to 60 years old),

          -  confirmed ureteral stone

          -  prescribed ureteral stent placement for pain syndrome relief

        Exclusion Criteria:

          -  an active urinary tract infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>First Pavlov Saint Petersburg University</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197342</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 23, 2019</study_first_submitted>
  <study_first_submitted_qc>June 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2019</study_first_posted>
  <last_update_submitted>June 25, 2019</last_update_submitted>
  <last_update_submitted_qc>June 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Petersburg State Pavlov Medical University</investigator_affiliation>
    <investigator_full_name>nariman.gadjiev</investigator_full_name>
    <investigator_title>Head of endourology</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

